. The effect of combination of HPMC K5M and EC, HPMC and sodium CMC, EC and sodium CMC, HPMC, EC and sodium CMC on response parameters like release pattern, cumulative percent release of the drug, drug release mechanism were studied. 
Infectious diseases are most common in developing countries. The infectious bacterial classes are both Gram positive and Gram negative hence, the treatment is necessary with an agent, which have broad spectrum of activity. Cephalosporins possess a wide range of activity against Gram positive and Gram negative bacteria; these are act by inhibiting bacterial cell wall synthesis. Cefixime trihydrate is an orally active third generation cephalosporins [1, 2] . Sustained release dosage forms have number of advantages over conventional dosage forms, improved patient convenience due to less frequent dosing, reduction in fluctuation in steady-state levels and therefore better control of disease, maximum utilization of drug enabling reduction in total amount of dose administered [3] [4] [5] . The objectives of the present work are to design, formulate and evaluate matrix tablets of cefixime trihydrate for sustained release dosage form. As the effect of sustained release dosage form is relatively more, incorporating the drug in the matrix tablet will prolong the drug release. These are prepared by direct compression method. The matrix tablets of cefixime trihydrate designed using polymers such as hydroxypropyl methylcellulose K5M (HPMC K5M), carboxymethyl cellulose sodium (sodium CMC) and ethyl cellulose (EC) and evaluated for various precompression and post-compression parameters
MATERIALS AND METHODS
Cefixime trihydrate, microcrystalline cellulose were purchased from KAPL., Bengaluru, India, HPMC K5M, EC and sodium CMC were purchased from Colorcon Asia Pvt. Ltd., Mumbai. Magnesium stearate was purchased from Loba Chemie Pvt. Ltd. Sodium Hydroxide, hydrochloric acid were purchased from S. D. Fine Chem. Limited, Mumbai and potassium dihydrogenortho-phospahte from Ranbaxy Fine Chemicals.
Fourier Transform Infrared (FTIR) spectroscopy:
The Fourier transform infrared (FTIR) spectra of samples were obtained using FTIR spectrophotometer (Perkin Elmer). Pure drug, individual polymers and optimized formulations were subjected to FTIR study. About 2-3 mg of sample was mixed with dried potassium bromide of equal weight and compressed to form a KBr disk. The samples were scanned from 500 to 4000 cm
Formulation of sustained release matrix tablets:
Sustained release matrix tablets were prepared by direct compression method as per the formula given in the Table 1 . Initially the drug was passed through Sieve #30, all the polymers were passed through Sieve #40 and microcrystalline cellulose and magnesium stearate were passed through Sieve #60. Required quantity of the drug, polymers and diluents were mixed thoroughly. This powder mixture was blended and compressed using a single punch-tableting machine (Cadmach Machinery Co. Pvt. Ltd) with hardness of the tablets maintained between 8-11 kg/cm [8, 9] .
Pre-compression evaluation parameters:
Bulk density is the ratio of total mass of powder to the bulk volume of powder. It was measured by pouring a weighed quantity of powder (passed through standard Sieve #20) into a measuring cylinder and the initial volume (bulk volume) was noted. From this, the bulk density is calculated. Tapped density is the ratio of total mass of powder to the tapped volume of powder. It was measured by pouring the weighed powder into a measuring cylinder and then it was subjected to 500 tappings from a height of 2 inches. The volume was measured and tapped density was calculated. Three determinations were done for each parameter [10] .
Hausner's ratio is the ratio of tapped density to bulk density. It was calculated by noted tapped density and poured density values. Carr's index was calculated as 100 times the ratio of the difference between tapped density and bulk density to the tapped density. It was measured by calculated tapped density and poured density values. These determinations were carried out in triplicate [10] . Angle of repose is defined as the maximum angle possible between the surface of a pile of powder and the horizontal plane; it was measured by pouring the weighed powder mixture into the funnel which was fixed to a stand at a definite height (h). The drug excipient blend was allowed to flow through the funnel freely on to the surface of a graph sheet. Then the height and diameter of the heap formed were noted and the angle of repose was calculated. Three determinations were performed [11] . The angle of repose can be calculated using the formula, Tan θ=h/r, where h is the height, r is the radius and θ is the angle of repose.
Post-compression evaluation for formulated matrix tablets:
Hardness or tablet crushing strength is the force required to break a tablet in a diametric compression. Hardness of the tablet was determined using the Monsanto hardness tester (Shreeji Chemicals). The hardness was computed by deducting the initial pressure from the final pressure. Test was performed on six tablets and average was calculated [12] . Weight variation was carried out according to European pharmacopoeia. Twenty tablets were selected at random and average weight was determined. Then individual tablets were weighed and the individual weight was compared with the average weight [12] . Three tablets were selected randomly from each batch HPMC is hydroxypropyl methylcellulose, sod CMC is sodium carboxy methylcellulose, EC is ethyl cellulose, and MCC is microcrystalline cellulose. All quantities are in mg and thickness was measured using vernier calipers. The tablet was placed between two arms of the vernier calipers and thickness was measured [12] . The Roche friability test apparatus (Roche Rich Pharma, Mumbai) was used to determine the friability of the tablets. This device chamber revolves at 25 rpm. About 10 tablets were selected randomly, dedusted and weighed. Then they were placed in the drum and rotated 100 times. Then tablets were dedusted again to remove loose dust and were reweighed. The percent loss in weight was calculated, which gave a measure of friability [12] .
Ten Tablets were selected randomly, weighed and average weight of the tablet calculated. Tablets were ground individually to a fine powder. Powder equivalent to 280 mg of cefixime trihydrate was transferred to a 100 ml volumetric flask, dissolved in 80 ml of pH 7.2 buffer. The volume was made up to 100 ml with the buffer and filtered through a Whatman filter paper. Absorbance of the sample solution was measured using UV/Vis spectrophotometer (Elico) and concentration of the drug in the sample was calculated [12] .
In vitro dissolution of sustained release tablets of cefixime trihydrate was studied in USP XXIII dissolution apparatus (Electro lab) rotated at 100 rpm. Nine hundred millilitres of pH 1.2 buffer for the 2 h, followed by pH 7.2 buffer for the next 10 h were used as the dissolution media. The temperature of dissolution medium was maintained at 37±0.5° throughout the experiment. One tablet was used in each test. Samples of dissolution medium (5 ml) were withdrawn using a syringe fitted with a pre-filter at known intervals of time and analyzed for drug content by measuring the absorbance at 288 nm. The volume withdrawn at each time interval was replaced with fresh quantity of dissolution medium. The dissolution studies were carried out in triplicate. Cumulative percent drug released was calculated and plotted against time [12] . and intercept the origin of the axes [13] . First order as log cumulative percent of drug remaining vs. time, and the Fisrt order Eqn. being LogC=LogC 0 − kt/2.303, where C 0 is the initial concentration of drug, k is the first order constant, and t is the time [13] . Higuchi's model, which is cumulative percent drug released vs. square root of time and the Higuchi Eqn. being, Q=K t 1/2 , where K is the constant reflecting the design variables of the system and t is the time in h. Hence, drug release rate is proportional to the reciprocal of the square root of time [14] . Korsmeyer Peppas Eqns were applied to evaluate the mechanism of drug release from the dosage form, data for the first 60% of drug release were plotted in Korsmeyer et al. proposed Eqn. log cumulative percent drug released vs. log time, and the exponent n was calculated through the slope of the straight line. Mt/M∞=Ktn, where Mt/M∞ is the fractional solute release, t is the release time, K is a kinetic constant characteristic of the drug/polymer system, and n is an exponent that characterizes the mechanism of release of tracers. For cylindrical matrix tablets, if the exponent n=0.45, then the drug release mechanism is Fickian diffusion, and if 0.45<n<0.89, then it is nonFickian or anomalous diffusion. An exponent value of 0.89 is indicative of Case-II Transport or typical zero-order release [15] . Table 2) . Angle of repose is defined as maximum angle possible between the surface of the pile of powder and the horizontal plane. Angle of repose values obtained ranged from 28.17° to 34.36° which are <35, indicative of good flow properties of granules, and it was observed to be within the pharmacopoeias limits ( Table 2) .
RESULTS AND DISCUSSION
The hardness of all the formulations ranged from 2.7 to 3.3 kg/cm 2 . The pharmacopoeial limit for hardness is 3-5 kg/cm 2 . Hence all the formulations passed the test for hardness ( Table 3 ). The weights of the tablets were between 500 to 504 mg, as the weight of the tablet is 500 mg the weight variation limit is ±5%. The pharmacopoeial specification for weight variation limit is ±5% for uncoated tablets weighing more than 324 mg. Hence all the formulations passed the weight variation test (Table 3) . The thickness of all the formulations was between 2.73 to 3.1 mm, which was according to the pharmacopoeial specifications. The tablet mean thickness was almost uniform in all the formulations (Table 3) . Friability of all the formulations was determined, and the values were in the range from 0.39 to 0.56%. Friability of the formulated tablets was found to be below 1%, which indicated good mechanical resistance of the tablets. Hence all the formulations were within the pharmacopoeial limits (Table 3) . Percent drug content of the drug in all the formulated tablets was found to be within limit. Percent drug content of cefixime trihydrate was within 98.21 to 102.5% for all the nine formulations. The results are within the range indicate uniformity of mixing. Table 3 shows data of drug content uniformity.
Results obtained in the in vitro drug release study of different formulations are shown in Table 4 . The data indicated that formulations F-1 released 99% of cefixime trihydrate at the 9th h, F-2 released 101.44% at the 6th hour, F-3 released 99.8% at the 11th hour, F-4 released 101.75% at the 9th hour, F-5 releases 102.15% at the 12th hour, F-6 released 100.99% at the 11th hour, F-7 released 99.89% at the 11th hour, F-8 released 99.78% at the 9th hour and Formulation F-9 releases100.97% of drug at the 9th hour. From the data obtained it was concluded that the formulation F-5 HPMC:EC in 1:1 ratio released 102.15 % of cefixime trihydrate in 12 h could be regarded as the best formulations.
Data of in vitro release were fitted to different Eqns and kinetic models to explain the release kinetics of cefixime trihydrate from the sustained release matrix tablet. The data were processed for regression analysis using MS-Excel statistical functions. To know the order of reaction from these formulations, the data were treated according to first-order (log cumulative percent drug remaining vs. time), Higuchi's (cumulative percent drug released vs. square root of time), and Korsmeyer Pappas's (log cumulative percent drug released vs. log time) Eqns along with zero order (cumulative amount of drug released vs. time) Eqn.
When the data were plotted according to the zero-order Eqn, the formulations showed fair linearity with regression values between 0.956 and 0.999, and when the data were plotted according to the first-order Eqn., the formulations showed regression values between 0.819 and 0.961. By studying the release kinetics of cefixime matrix tablets, the formulations did not follow a first-order release pattern but a zeroorder release pattern ( Table 5 ).
The in vitro release profiles of drug from all the formulations could be best expressed by Higuchi's Eqn., as the plots showed high linearity with R 2 values 
